Jeonjinbio has been growing earnings at an average annual rate of 39.2%, while the Chemicals industry saw earnings declining at 0.3% annually. Revenues have been growing at an average rate of 29.4% per year. Jeonjinbio's return on equity is 0.1%, and it has net margins of 0.1%.
How Jeonjinbio makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
KOSDAQ:A110020 Revenue, expenses and earnings (KRW Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
31 Mar 26
14,421
17
3,385
422
31 Dec 25
13,694
-196
3,426
438
30 Sep 25
14,654
728
3,040
429
30 Jun 25
15,451
956
3,034
399
31 Mar 25
17,022
4,245
3,218
370
31 Dec 24
19,273
4,346
3,359
362
30 Sep 24
19,959
978
3,572
395
30 Jun 24
19,142
-201
3,792
430
31 Mar 24
17,686
-5,550
3,841
455
31 Dec 23
15,681
-6,440
3,937
448
30 Sep 23
13,204
-4,327
3,914
419
30 Jun 23
10,893
-4,905
3,753
425
31 Mar 23
9,055
-2,999
3,560
405
31 Dec 22
7,794
-3,113
3,373
422
30 Sep 22
5,899
-2,504
3,384
399
30 Jun 22
4,557
-2,228
3,374
371
31 Mar 22
3,457
-2,462
3,328
411
31 Dec 21
3,214
-2,108
3,716
364
30 Sep 21
3,496
-3,609
3,793
375
30 Jun 21
3,796
-3,275
3,698
352
31 Mar 21
3,910
-3,882
3,794
346
31 Dec 20
3,867
-3,418
3,400
345
30 Sep 20
4,732
-1,604
3,677
353
30 Jun 20
4,643
-1,648
3,756
447
31 Mar 20
4,426
-1,330
3,532
416
31 Dec 19
3,949
-1,462
3,194
465
30 Sep 19
2,230
-3,437
3,008
532
30 Jun 19
1,357
-3,579
2,587
458
31 Mar 19
1,243
-3,495
2,452
428
31 Dec 18
1,384
-3,399
2,502
361
30 Sep 18
2,216
-3,610
3,325
258
30 Jun 18
2,392
-3,366
3,287
219
31 Mar 18
2,792
-3,130
3,302
209
31 Dec 17
3,136
-3,041
3,442
192
30 Sep 17
2,645
-2,626
2,698
183
30 Jun 17
3,106
-3,325
3,491
198
31 Mar 17
2,895
-3,697
3,461
233
31 Dec 16
4,809
-3,074
4,439
196
31 Dec 15
2,018
-2,931
2,597
37
Quality Earnings: A110020 has high quality earnings.
Growing Profit Margin: A110020's current net profit margins (0.1%) are lower than last year (24.9%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A110020 has become profitable over the past 5 years, growing earnings by 39.2% per year.
Accelerating Growth: A110020's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: A110020 had negative earnings growth (-99.6%) over the past year, making it difficult to compare to the Chemicals industry average (-3.5%).
Return on Equity
High ROE: A110020's Return on Equity (0.1%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/06/10 11:10
End of Day Share Price
2026/06/10 00:00
Earnings
2026/03/31
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Jeonjinbio Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.